1. Home
  2. NSSC vs NVCR Comparison

NSSC vs NVCR Comparison

Compare NSSC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

N/A

Current Price

$42.65

Market Cap

1.3B

ML Signal

N/A

Logo NovoCure Limited

NVCR

NovoCure Limited

N/A

Current Price

$12.71

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSSC
NVCR
Founded
1969
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NSSC
NVCR
Price
$42.65
$12.71
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$47.50
$28.42
AVG Volume (30 Days)
386.8K
1.8M
Earning Date
02-02-2026
10-30-2025
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
1.23
N/A
Revenue
$186,786,000.00
$642,269,000.00
Revenue This Year
$13.13
$9.75
Revenue Next Year
$9.55
$5.62
P/E Ratio
$34.50
N/A
Revenue Growth
N/A
11.17
52 Week Low
$19.00
$10.70
52 Week High
$48.12
$34.13

Technical Indicators

Market Signals
Indicator
NSSC
NVCR
Relative Strength Index (RSI) 55.45 52.61
Support Level $40.99 $10.79
Resistance Level $43.21 $13.94
Average True Range (ATR) 1.50 0.63
MACD 0.29 0.12
Stochastic Oscillator 88.20 60.63

Price Performance

Historical Comparison
NSSC
NVCR

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: